ABSTRACT

Purpose:

This review article aims to evaluate new information on prostate cancer screening, diagnosis and clinical considerations according to nexly updated EAU and AUA guidelines.

Conclusion:

Due to high inidence of prostate cancer and with thepurpose of reducing prostate cancer mortality as well as increasing quality of life in prostate cancer patients, screening has become a very important healthissue. Screening appears to accomplish the abovementioned tasks; but at thecost of a high rate of over-diagnosisandover-treatment. Therefore, currentguidelinesshould be meticuloulyfollowedregardingwhomand how toscreen. Patients should be thoroughly informed on screening and its consequences. Patients' participation is of paramount importantance on the decison to screen.